[ALA] YoY Quarter Result on 31-Dec-2012 [#Q2]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Dec-2012
Financial Year
2013
Quarter
31-Dec-2012 [#Q2]
Profit Trend
QoQ- 0.00%
YoY-
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
Revenue 427 202 195 1,419 1,523 3,121 1,048 -13.89%
PBT -435 -1,113 -527 -906 -979 -166 -483 -1.72%
Tax 0 0 56 0 -6 0 0 -
NP -435 -1,113 -471 -906 -972 -166 -483 -1.72%
Tax Rate - - - - - - - -
Total Cost 862 1,315 666 2,325 2,495 3,287 1,531 -9.12%
Ratio Analysis
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
NP Margin -101.83 -551.87 -240.94 -63.82 -63.87 -5.32 -46.09 14.11%
Per Share
31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 31/12/12 CAGR
EPS -0.00 -0.02 -0.01 -0.02 -0.03 -0.01 -0.02 -
EPS Diluted -0.00 -0.02 -0.01 -0.02 -0.02 -0.00 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.